Raphael Pharmaceutical (RAPH) Return on Assets (2021 - 2025)
Raphael Pharmaceutical (RAPH) reported Return on Assets of 1.04% for Q3 2025, down 79.0% on a YoY basis from 4.97% in Q3 2024, and down 185.32% sequentially from 0.37% in Q2 2025.
Raphael Pharmaceutical (RAPH) Return on Assets (2021 - 2025) Analysis & Trends
Raphael Pharmaceutical (RAPH) has 5 years of Return on Assets data on file, last reported at 1.04% in Q3 2025.
- For the quarter ending Q3 2025, Return on Assets fell 79.0% year-over-year to 1.04%; the trailing twelve-month figure through Sep 2025 stood at 1.04% (down 79.0% YoY), and the FY2025 full-year result was 0.81%, down 58.0% from the prior year.
- Return on Assets fell to 1.04% in Q3 2025, from 0.37% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.08% in Q4 2023 to a low of 1.04% in Q3 2025.
- A 5-year average of 0.28% and a median of 0.17% in 2022 frame the typical range for Return on Assets.
- Across the five-year window, Return on Assets advanced 18 bps in 2024 and tumbled 79 bps in 2025, its largest moves.
- Tracing RAPH's Return on Assets over 5 years: stood at 0.12% in 2021, then tumbled by 50 bps to 0.18% in 2022, then soared by 56 bps to 0.08% in 2023, then plunged by 887 bps to 0.78% in 2024, then slumped by 34 bps to 1.04% in 2025.
- Business Quant data shows RAPH's Return on Assets at 1.04% in Q3 2025, 0.37% in Q2 2025, and 0.42% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 0.00% |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.00% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.00% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.00% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.00% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.00% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.00% |
| 10 | Raphael Pharmaceutical | 27.37 Mn | 27.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.04% |
| Jun 30, 2025 | -0.37% |
| Mar 31, 2025 | -0.42% |
| Dec 31, 2024 | -0.78% |
| Sep 30, 2024 | -0.25% |
| Jun 30, 2024 | -0.11% |
| Mar 31, 2024 | -0.10% |
| Dec 31, 2023 | -0.08% |
| Sep 30, 2023 | -0.12% |
| Jun 30, 2023 | -0.29% |
| Mar 31, 2023 | -0.17% |
| Dec 31, 2022 | -0.18% |
| Sep 30, 2022 | -0.25% |
| Jun 30, 2022 | -0.16% |
| Mar 31, 2022 | -0.09% |
| Dec 31, 2021 | -0.12% |